Global Prader-Willi Syndrome Market Size To Worth USD 1131.94 Million By 2033 | CAGR of 6.56%
Category: HealthcareGlobal Prader-Willi Syndrome Market Size To Worth USD 1131.94 Million By 2033
According to a research report published by Spherical Insights & Consulting, the Global Prader-Willi Syndrome Market Size is Expected to Grow from USD 599.81 Million in 2023 to USD 1131.94 Million By 2033, at a CAGR of 6.56% during the Forecast Period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 240 pages with 130 Market data tables and figures & charts from the report on The " Global Prader-Willi Syndrome Market Size, Share, and COVID-19 Impact Analysis, By Growth Hormone Therapy (Norditropin, Omnitrope, and Genotropin), By Hyperphagia Treatment (Carbetocin, ARD-101, and DCCR), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023-2033" Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/prader-willi-syndrome-market
Prader-Willi syndrome is a rare genetic disorder affecting the body's metabolism and neurological, endocrine, and metabolic systems. It causes severe hypotonia, poor appetite, and feeding difficulties in early childhood due to the lack of expression of paternally inherited genes. The disease is characterized by facial features, strabismus, and musculoskeletal anomalies, leading to behavioral and intellectual problems and global developmental delays. About 25% of cases are caused by maternal uniparental disomy, while 70% are caused by genomic imprinting abnormalities caused by a paternal deletion. The disease is rare in parents with multiple children. Human growth hormone (HGH) therapy is widely recommended for children and newborns with PWS, improving mobility, reducing fat mass, and preventing behavioral issues. Government initiatives, such as the Indian government's Umbrella Scheme, increase awareness of rare diseases and the demand for therapeutic drugs for PWS management, driving market growth. However, the limited awareness of the disease and medications may hinder market growth.
The genotropin segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the growth hormone therapy, the global Prader-Willi syndrome market is categorized as norditropin, omnitrope, and genotropin. Among these, the genotropin segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. This is driven by reducing excess body fat, improving growth and composition, increasing growth hormone levels, and enhancing muscle strength.
The DDCR segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the hyperphagia treatment, the global Prader-Willi syndrome market is categorized as carbetocin, ARD-101, and DCCR. Among these, the DDCR segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. Improved aggressive behavior, improved metabolic parameters, decreased hyperphagia intensity, and improved overall sickness severity in an individual are some of the elements that contribute to the sector's growth.
North America is expected to hold the greatest share of the global Prader-Willi syndrome market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global Prader-Willi syndrome market over the forecast period. The North American Prader-Willi syndrome (PWS) market is experiencing significant economic growth, with pharmaceutical companies, healthcare providers, and research institutes investing in holistic care models and individualized treatment. Governments and nonprofit groups are supporting the market by establishing specialized institutions, funding research, and improving treatment accessibility. Awareness efforts are reducing stigma, increasing early diagnosis rates, and utilizing technological integration for better monitoring and management.
Asia Pacific is predicted to grow at the fastest throughout the estimated period. The Asia Pacific Prader-Willi Syndrome (PWS) market is growing due to government initiatives, increased healthcare spending, and clinical trials. Government legislation improves the diagnosis and treatment of rare diseases, while growing healthcare spending improves access to specialized therapies. The region is emerging as a clinical trial center due to reduced costs and a diverse population. Medical tourism attracts patients, and cooperation between NGOs and medical facilities raises awareness of PWS, enabling earlier detection and treatment.
Major key players in the global Prader-Willi syndrome market are Sarepta Therapeutics, Novartis, Rhythm Pharmaceuticals, Kezar Life Sciences, Axovant Gene Therapies, Genentech, Eli Lilly Company, Newron Pharmaceuticals, Corcept Therapeutics, Soleno Therapeutics, Novartis AG, Novo Nordisk, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In April 2025, Soleno Therapeutics developed the VYKATTMXR (diazoxide choline) extended-release tablets, and approved by the United States Food and Drug Administration (USFDA). This drug is the first approved treatment for hyperphagia in Prader-Willi syndrome.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global Prader-Willi syndrome market based on the below-mentioned segments:
Global Prader-Willi Syndrome Market, By Growth Hormone Therapy
- Norditropin
- Omnitrope
- Genotropin
Global Prader-Willi Syndrome Market, By Hyperphagia Treatment
- Carbetocin
- ARD-101
- DCCR
Global Prader-Willi Syndrome Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?